Physician profile
Michelle Chaney
NPI 1528030988
$3,698.25
in general payments reported to CMS, 2019-2025
17 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $12.92 · 2021: $204 · 2022: $202 · 2023: $158 · 2024: $2,515 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,078.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,103.78 | 2019-2025 | Dailies Total1, Air Optix Color, Precision 1 |
| Harrow Eye, LLC | $266.81 | 2024-2025 | Vevye |
| Allergan, INC. | $230.93 | 2019-2022 | |
| Coopervision INC. | $162.00 | 2024-2025 | Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $151.43 | 2023-2025 | Miebo, Vyzulta, Scoutpro Osmolarity System |
| Johnson & Johnson Vision Care, INC. | $146.79 | 2021-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $138.53 | 2024-2025 | Xdemvy |
| Ivantis, INC | $133.79 | 2021 | |
| Novartis Pharmaceuticals Corporation | $100.55 | 2022-2023 | |
| Abbvie INC. | $80.05 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $37.59 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $31.27 | 2022 | |
| Oyster Point Pharma, INC. | $29.81 | 2025 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $26.27 | 2019 | |
| Biotissue Holdings INC. | $21.23 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $19.15 | 2019 | |
| Shire North American Group INC | $18.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Chaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.